Data Collective IV GP, LLC

Holdings History for RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

Symbol: RXRX on Nasdaq
Investment type: Equity / Class A Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
31 Dec 2025	42%	0%	$24,299,181	5,941,120	$4.09	Q4 2025
30 Sep 2025	43%	0%	$28,992,666	5,941,120	$4.88	Q3 2025
30 Jun 2025	23%	0%	$30,062,067	5,941,120	$5.06	Q2 2025
31 Mar 2025	36%	0%	$31,428,525	5,941,120	$5.29	Q1 2025
31 Dec 2024	18%	0%	$40,161,971	5,941,120	$6.76	Q4 2024
30 Sep 2024	24%	0%	$39,151,981	5,941,120	$6.59	Q3 2024
30 Jun 2024	31%	0%	$44,558,400	5,941,120	$7.50	Q2 2024
31 Mar 2024	51%	0%	$59,232,966	5,941,120	$9.97	Q1 2024
31 Dec 2023	48%	0%	$58,579,443	5,941,120	$9.86	Q4 2023
30 Sep 2023	43%	0%	$45,449,568	5,941,120	$7.65	Q3 2023
30 Jun 2023	33%	0%	$44,380,166	5,941,120	$7.47	Q2 2023
31 Mar 2023	42%	0%	$39,627,270	5,941,120	$6.67	Q1 2023
31 Dec 2022	48%	0%	$45,806,035	5,941,120	$7.71	Q4 2022
30 Sep 2022	50%	0%	$63,214,000	5,941,120	$10.64	Q3 2022
30 Jun 2022	40%	0%	$48,361,000	5,941,120	$8.14	Q2 2022
31 Mar 2022	9%	0%	$42,538,000	5,941,120	$7.16	Q1 2022
31 Dec 2021	14%	0%	$101,771,000	5,941,120	$17.13	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.